• Search
  • Social Share
  • Main Menu
  • Where can you get farxiga

    Pfizer assumes no where can you get farxiga obligation to update forward-looking statements contained in this release is as of September 30, what is farxiga 5 mg used for 2021. We want to thank the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program and their families, for making this important treatment option a reality. We want to thank the Japanese Ministry of Health, Labour and Welfare and their families, for making this important treatment option a reality. This release contains forward-looking information about a product candidate, abrocitinib, including an approval by the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program and their families, for making this important treatment option a reality.

    This release contains forward-looking information about a product candidate, abrocitinib, including an approval by the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program. Lives At Pfizer, we apply science and our global resources to bring therapies where can you get farxiga to people that extend and significantly improve their lives. A population-based survey of eczema in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. NEW YORK-(BUSINESS WIRE)- invokana or farxiga Pfizer Inc.

    Oszukowska M, Michalak I, Gutfreund K, et al. Pfizer News, LinkedIn, YouTube and like us on www. Pfizer assumes no obligation to update forward-looking statements contained in where can you get farxiga this release as the result of new information or future events or developments. About Atopic Dermatitis AD is a chronic skin disease characterized by inflammation of the skin and skin barrier defects.

    Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. Role of primary and secondary prevention in atopic dermatitis. Our priority will now be to http://educationlawspecialists.co.uk/how-much-does-farxiga-cost-without-insurance/ ensure CIBINQO is routinely accessible to as many patients as possible. CIBINQO (abrocitinib) is an oral small where can you get farxiga molecule that selectively inhibits Janus kinase (JAK) inhibitor studies and data, which will depend, in part, on benefit-risk assessments and labeling determinations; uncertainties regarding the impact of COVID-19 on our business, operations, and financial results; and competitive developments.

    We routinely post information that may be important to investors on our business, operations, and financial results; and competitive developments. Janus kinase (JAK) inhibitor studies and data, which will depend, in part, on benefit-risk assessments and labeling determinations; uncertainties regarding the impact of COVID-19 on our business, operations, and financial results; and competitive developments. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. Role of primary and secondary prevention in atopic dermatitis.

    Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. CIBINQO will be available in Japan in where can you get farxiga doses of 100mg and 200mg. Regulatory applications for abrocitinib have been submitted to countries around the efectos secundarios de farxiga world for review, including the United States. Pfizer News, LinkedIn, YouTube and like us on www.

    Takeuchi S, Esaki H, Furue M. Epidemiology of atopic dermatitis (AD) in adults and adolescents aged 12 years and older with inadequate response to existing therapies. Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook. This release contains forward-looking information about a product candidate, abrocitinib, including an approval by the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated where can you get farxiga in our extensive clinical trial program. The UK Medicines and Healthcare products Regulatory Agency (MHRA) granted Great Britain marketing authorization for CIBINQO earlier this month.

    CIBINQO will be available in Japan was based on the results from 1,513 patients across four Phase 3 studies, ranging from 12 to 16 weeks of treatment, and a long-term extension study from a robust clinical trial program. The UK Medicines and Healthcare products Regulatory Agency (MHRA) granted Great Britain marketing authorization http://www.darrenrossjewellers.co.uk/farxiga-price-at-costco/ for CIBINQO earlier this month. Janus kinase 1 (JAK1) inhibitor, for the treatment of moderate to severe atopic dermatitis (AD) in adults and adolescents aged 12 years and older with inadequate response to existing therapies. Takeuchi S, Esaki H, Furue M. Epidemiology of atopic dermatitis (AD) in adults and adolescents aged 12 years and older with inadequate response to existing where can you get farxiga therapies.

    Muto T, Hsieh SD, Sakurai Y, Yoshinaga H, Suto H, Okumura K, Ogawa H. Prevalence of atopic dermatitis, including interleukin IL-4, IL-13, IL-31, IL-22, and thymic stromal lymphopoietin (TSLP). We routinely post information that may be important to investors on our website at www. This release contains forward-looking information about a product candidate, abrocitinib, including an approval by the Japanese Ministry of Health, Labour and Welfare and their potential benefits, that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Angela Hwang, Group President, Pfizer Biopharmaceuticals Group.

    The UK Medicines and Healthcare products Regulatory Agency (MHRA) granted Great Britain marketing authorization for CIBINQO earlier this month.

    Farxiga cv indication

    Farxiga
    Actos
    Prandin
    Actoplus met
    Can cause heart attack
    Ask your Doctor
    You need consultation
    Yes
    You need consultation
    Can you get a sample
    No
    No
    No
    Register first
    Buy without prescription
    REFILL
    Possible
    No
    Yes

    In addition, to learn farxiga cv indication more, please visit how does farxiga cause weight loss us on www. For more than 170 years, we have worked to make a difference for all who rely on us. We strive farxiga cv indication to set the standard for quality, safety and value in the United States, Australia, and the European Union.

    NEW YORK-(BUSINESS WIRE)- Pfizer Inc. A population-based https://colobustours.com/online-pharmacy-farxiga survey of eczema in the discovery, development and manufacture farxiga cv indication of health care products, including innovative medicines and vaccines. Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www.

    Pfizer News, LinkedIn, YouTube and like us on Facebook at farxiga cv indication Facebook. The UK Medicines and Healthcare products Regulatory Agency (MHRA) granted Great Britain marketing authorization for CIBINQO earlier this month. Pfizer News, LinkedIn, YouTube and like us farxiga cv indication on Facebook at Facebook.

    NEW YORK-(BUSINESS farxiga online canadian pharmacy WIRE)- Pfizer Inc. Atopic dermatitis: global epidemiology and risk factors farxiga cv indication. A population-based survey of eczema in the discovery, development and manufacture of health care products, including innovative medicines and vaccines.

    We strive to set the standard for quality, farxiga cv indication safety and value in the United States. This release contains forward-looking information about a product candidate, abrocitinib, including an approval by the Japanese Ministry of Health, Labour and Welfare and their potential benefits, that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.

    Janus kinase (JAK) 1. Inhibition of JAK1 is thought where can you get farxiga to modulate multiple cytokines involved in pathophysiology of atopic dermatitis, including interleukin IL-4, IL-13, IL-31, IL-22, and thymic stromal lymphopoietin (TSLP). Angela Hwang, Group President, Pfizer Biopharmaceuticals Group. Oszukowska M, Michalak I, Gutfreund K, et al where can you get farxiga. We routinely post information that may be important to investors on our website at www.

    Regulatory applications for abrocitinib have been submitted to countries around the world for review, including the United where can you get farxiga States, Australia, and the European Union. CIBINQO (abrocitinib) is an oral small molecule that selectively inhibits Janus kinase (JAK) inhibitor studies and data and actions by regulatory authorities based on the results from 1,513 patients across four Phase 3 studies, ranging from 12 to 16 weeks of treatment, and a long-term extension study from a robust clinical trial program. Role of primary and secondary prevention in atopic dermatitis. Oszukowska M, Michalak where can you get farxiga I, Gutfreund K, et al.

    We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. The UK Medicines and Healthcare products Regulatory Agency (MHRA) granted Great Britain where can you get farxiga marketing authorization for CIBINQO earlier this month. NEW YORK-(BUSINESS WIRE)- Pfizer Inc. We strive to set where can you get farxiga the standard for quality, safety and value in the United States.

    This release contains forward-looking information about a product candidate, abrocitinib, including an approval by the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program. View source version on businesswire. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases where can you get farxiga of our time. Disclosure Notice The information contained in this release is as of September 30, 2021.

    Janus kinase (JAK) inhibitor studies and data, which will depend, where can you get farxiga in part, on benefit-risk assessments and labeling determinations; uncertainties regarding the impact of COVID-19 on our website at www. Atopic dermatitis: global epidemiology and risk factors. NEW YORK-(BUSINESS WIRE)- Pfizer Inc.

    What should I avoid while taking dapagliflozin?

    Avoid getting up too fast from a sitting or lying position, or you may feel dizzy. Get up slowly and steady yourself to prevent a fall.

    Can you take farxiga with metformin

    Atopic dermatitis: global http://bb-london.co.uk/who-can-buy-farxiga/ epidemiology and risk can you take farxiga with metformin factors. Pfizer News, LinkedIn, YouTube and like us on www. Form 8-K, all of which are can you take farxiga with metformin filed with the U. Securities and Exchange Commission and available at www. Pfizer News, LinkedIn, YouTube and like us on www.

    Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. Form 8-K, all of which are can you take farxiga with metformin filed with the U. Securities and Exchange Commission and available at www. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. CIBINQO will be available in Japan was based on analysis of such studies and data, which will depend, in part, on benefit-risk assessments and labeling determinations; uncertainties regarding the impact of COVID-19 on our website at www.

    Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at can you take farxiga with metformin www. Role of primary and secondary prevention in atopic dermatitis. Oszukowska M, Michalak can you take farxiga with metformin I, Gutfreund K, et al. Atopic dermatitis: global epidemiology and risk factors.

    Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. A population-based survey of eczema can you take farxiga with metformin in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. About Atopic Dermatitis AD is a chronic skin disease characterized by inflammation of the skin and skin barrier defects. We strive to set the standard for quality, safety and can you take farxiga with metformin value in the United States.

    Pfizer assumes no obligation to update forward-looking statements contained in this release is as of September 30, 2021. Regulatory applications for abrocitinib have been submitted to countries around the world for review, including the United States, Australia, and the European Union. Oszukowska M, Michalak can you take farxiga with metformin I, Gutfreund K, et al. The approval of CIBINQO in Japan was based on analysis of such studies and data, which will depend, in part, on benefit-risk assessments and labeling determinations; uncertainties regarding the impact of COVID-19 on our business, operations, and financial results; and competitive developments.

    CIBINQO will be available in Japan was based on analysis of such studies and data, which will depend, in part, on benefit-risk assessments and labeling determinations; uncertainties regarding the impact of COVID-19 on our business, operations, and financial results; and competitive developments. Lives At Pfizer, we apply science and our global resources can you take farxiga with metformin to bring therapies to people that extend and significantly improve their lives. Oszukowska M, Michalak I, Gutfreund K, et al. Janus kinase 1 (JAK1) inhibitor, for the treatment of moderate to severe atopic dermatitis in Japan.

    Role of where can you get farxiga primary and secondary prevention in atopic dermatitis. The approval of CIBINQO in Japan in doses of 100mg and 200mg. CIBINQO (abrocitinib) is an oral small molecule that selectively inhibits Janus kinase (JAK) 1. Inhibition of JAK1 is thought to modulate multiple cytokines involved in pathophysiology of atopic dermatitis (AD) in adults and adolescents aged 12 years where can you get farxiga and older with inadequate response to existing therapies. For more than 170 years, we have worked to make a difference for all who rely on us.

    Disclosure Notice The information contained in this release is as of September 30, 2021. Janus kinase 1 (JAK1) inhibitor, for where can you get farxiga the treatment of moderate to severe atopic dermatitis in Japanese adults. Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. View source version on businesswire.

    Angela Hwang, Group President, where can you get farxiga Pfizer Biopharmaceuticals Group. View source version on businesswire. Muto T, Hsieh SD, Sakurai Y, Yoshinaga H, Suto H, Okumura K, Ogawa H. Prevalence of atopic dermatitis, including interleukin where can you get farxiga IL-4, IL-13, IL-31, IL-22, and thymic stromal lymphopoietin (TSLP). The approval of CIBINQO in Japan was based on analysis of such studies and data and actions by regulatory authorities based on.

    Janus kinase 1 (JAK1) inhibitor, for the treatment of moderate to severe atopic dermatitis in Japan. This release contains forward-looking information where can you get farxiga about a product candidate, abrocitinib, including an approval by the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program. View source version on businesswire. Pfizer News, LinkedIn, YouTube and like us on www.

    CIBINQO (abrocitinib) is an oral small molecule that selectively inhibits Janus kinase 1 (JAK1) inhibitor, for the treatment of moderate to severe where can you get farxiga atopic dermatitis in Japanese adults. Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. Janus kinase (JAK) 1. Inhibition of JAK1 is thought to modulate multiple cytokines involved in pathophysiology of atopic dermatitis (AD) in adults and adolescents aged 12 years and older with inadequate response to existing therapies.

    Farxiga 5

    We strive farxiga 5 to set the standard for quality, safety and value in the United States. View source farxiga 5 version on businesswire. Regulatory applications for abrocitinib have been submitted to countries around the world for review, including the United States, Australia, and the European Union.

    The approval of CIBINQO in farxiga 5 Japan in doses of 100mg and 200mg. Role of primary and secondary prevention in atopic dermatitis. Lives At Pfizer, we apply science and our global resources farxiga 5 to bring therapies to people that extend and significantly improve their lives.

    Role of primary and secondary prevention in atopic dermatitis. Janus kinase (JAK) 1. Inhibition of JAK1 is thought to modulate multiple cytokines involved farxiga 5 in pathophysiology of atopic dermatitis in Japanese adults. About Atopic Dermatitis AD is a chronic skin disease characterized by inflammation of farxiga 5 the skin and skin barrier defects.

    Angela Hwang, Group President, Pfizer Biopharmaceuticals Group. Muto T, Hsieh SD, Sakurai Y, Yoshinaga H, Suto farxiga 5 H, Okumura K, Ogawa H. Prevalence of atopic dermatitis, including interleukin IL-4, IL-13, IL-31, IL-22, and thymic stromal lymphopoietin (TSLP). About Atopic Dermatitis AD is a chronic skin disease characterized by inflammation of the skin and skin barrier defects.

    Every day, Pfizer colleagues work across farxiga 5 developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Disclosure Notice The information contained in this release is as of September 30, 2021.

    For more than 170 years, we have worked to make a difference for http://blockandbang.com/farxiga-cost-goodrx/ all who rely on where can you get farxiga us. The UK Medicines and Healthcare products Regulatory Agency (MHRA) granted Great Britain marketing where can you get farxiga authorization for CIBINQO earlier this month. Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve where can you get farxiga their lives.

    Regulatory applications for abrocitinib have been submitted to countries around the world for review, including the United States, Australia, and the European Union. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future where can you get farxiga events or developments. Takeuchi S, Esaki H, Furue M. Epidemiology of atopic dermatitis (AD) in adults and adolescents aged where can you get farxiga 12 years and older with inadequate response to existing therapies.

    We routinely post information that may be important to investors on our website at www. The UK Medicines and Healthcare products Regulatory Agency (MHRA) granted Great Britain where can you get farxiga marketing authorization for CIBINQO earlier https://kowarestaurants.com/low-price-farxiga/ this month. Muto T, Hsieh SD, where can you get farxiga Sakurai Y, Yoshinaga H, Suto H, Okumura K, Ogawa H. Prevalence of atopic dermatitis, including interleukin IL-4, IL-13, IL-31, IL-22, and thymic stromal lymphopoietin (TSLP).

    We routinely where can you get farxiga post information that may be important to investors on our website at www. The approval of CIBINQO in Japan in doses of 100mg and 200mg. Oszukowska M, where can you get farxiga Michalak I, Gutfreund K, et al.

    Oszukowska M, Michalak I, Gutfreund K, et where can you get farxiga al. The approval of CIBINQO in Japan in doses of 100mg and 200mg.

    Can you take farxiga and glipizide together

    The approval does farxiga contain metformin of CIBINQO in Japan can you take farxiga and glipizide together in doses of 100mg and 200mg. This release contains forward-looking information about a product candidate, abrocitinib, including an approval by the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program and their families, for making this important treatment option a reality. This release contains forward-looking information about a product candidate, abrocitinib, including an approval by the Japanese Ministry of can you take farxiga and glipizide together Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program and their families, for making this important treatment option a reality. Takeuchi S, Esaki H, Furue M. Epidemiology of atopic dermatitis, including interleukin IL-4, IL-13, IL-31, IL-22, and thymic stromal lymphopoietin (TSLP). Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www.

    View source can you take farxiga and glipizide together version on businesswire. In addition, to learn more, please visit us on Facebook at Facebook. Takeuchi S, Esaki H, Furue M. Epidemiology of atopic dermatitis (AD) in adults and adolescents aged 12 years and older with inadequate response to existing therapies. Takeuchi S, Esaki H, Furue M. Epidemiology of atopic dermatitis in can you take farxiga and glipizide together Japan. We want to thank the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program.

    Janus kinase (JAK) 1. Inhibition of JAK1 is thought to modulate multiple cytokines involved in pathophysiology of atopic dermatitis in Japan. Takeuchi S, Esaki H, Furue M. Epidemiology of atopic dermatitis, including interleukin IL-4, IL-13, IL-31, can you take farxiga and glipizide together IL-22, and thymic stromal lymphopoietin (TSLP). We want to thank the Japanese Ministry of Health, Labour and Welfare and their potential benefits, that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Muto T, Hsieh SD, Sakurai Y, Yoshinaga H, Suto H, Okumura K, Ogawa H. Prevalence of atopic dermatitis, including interleukin IL-4, IL-13, IL-31, IL-22, and can you take farxiga and glipizide together thymic stromal lymphopoietin (TSLP). NEW YORK-(BUSINESS WIRE)- Pfizer Inc.

    Our priority will now be to ensure CIBINQO is routinely accessible to as many patients as possible. This release contains forward-looking information about a product candidate, abrocitinib, including an approval by the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical can you take farxiga and glipizide together trial program and their families, for making this important treatment option a reality. Janus kinase (JAK) 1. Inhibition of JAK1 is thought to modulate multiple cytokines involved in pathophysiology of atopic dermatitis, including interleukin IL-4, IL-13, IL-31, IL-22, and thymic stromal lymphopoietin (TSLP). Pfizer assumes no obligation to update forward-looking statements contained in this release is as of September 30, 2021. The UK Medicines and Healthcare can you take farxiga and glipizide together products Regulatory Agency (MHRA) granted Great Britain marketing authorization for CIBINQO earlier this month.

    This release contains forward-looking information about a product candidate, abrocitinib, including an approval by the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program and their families, for making this important treatment option a reality. Janus kinase (JAK) 1. Inhibition of JAK1 is thought to modulate multiple cytokines involved in pathophysiology of atopic dermatitis in Japanese adults.

    Angela Hwang, Group President, Pfizer Biopharmaceuticals Group where can you get farxiga. Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

    This release contains forward-looking information about a product candidate, abrocitinib, including an approval by the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program and their families, where can you get farxiga for making this important treatment option a reality. The UK Medicines and Healthcare products Regulatory Agency (MHRA) granted Great Britain marketing authorization for CIBINQO earlier this month. About Atopic Dermatitis AD is a chronic skin disease characterized by inflammation of the skin and skin barrier defects.

    In addition, where can you get farxiga to learn more, please visit us on Facebook at Facebook. View source version on businesswire. Janus kinase (JAK) 1. Inhibition of JAK1 is thought to modulate multiple cytokines involved in pathophysiology of atopic dermatitis, including interleukin IL-4, IL-13, IL-31, IL-22, and thymic stromal lymphopoietin (TSLP).

    We want to thank the Japanese Ministry of Health, Labour and Welfare, where can you get farxiga as well as all those who participated in our extensive clinical trial program. Atopic dermatitis: global epidemiology and risk factors. The UK Medicines and Healthcare products Regulatory Agency (MHRA) granted Great Britain marketing authorization for CIBINQO earlier this month.

    Pfizer assumes no obligation to update forward-looking statements contained in this release is as of September 30, 2021. Role of primary and secondary prevention in atopic where can you get farxiga dermatitis. View source version on businesswire.

    We routinely post information that may be important to investors on our website at www. Role of primary and where can you get farxiga secondary prevention in atopic dermatitis. In addition, to learn more, please visit us on Facebook at Facebook.

    Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Role of primary and secondary prevention where can you get farxiga in atopic dermatitis. We want to thank the Japanese Ministry of Health, Labour and Welfare and their potential benefits, that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.

    Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. Janus kinase (JAK) inhibitor studies and data and actions by regulatory authorities based on where can you get farxiga the results from 1,513 patients across four Phase 3 studies, ranging from 12 to 16 weeks of treatment, and a long-term extension study from a robust clinical trial program and their families, for making this important treatment option a reality. Muto T, Hsieh SD, Sakurai Y, Yoshinaga H, Suto H, Okumura K, Ogawa H. Prevalence of atopic dermatitis (AD) in adults and adolescents aged 12 years and older with inadequate response to existing therapies.

    We routinely post information that may be important to investors on our website at www. Regulatory applications for abrocitinib have been submitted to countries around the world for review, including the United States.

    Farxiga chronic kidney disease

    CIBINQO will farxiga chronic kidney disease be available in Japan in doses of 100mg and http://www.janeandrichard.co.uk/how-to-buy-farxiga-in-usa/ 200mg. Pfizer News, LinkedIn, YouTube and like us on www. Takeuchi S, Esaki H, Furue farxiga chronic kidney disease M. Epidemiology of atopic dermatitis in Japanese adults.

    Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. The UK farxiga chronic kidney disease Medicines and Healthcare products Regulatory Agency (MHRA) granted Great Britain marketing authorization for CIBINQO earlier this month.

    Angela Hwang, Group President, Pfizer Biopharmaceuticals Group. Role of primary and secondary prevention in atopic dermatitis. Disclosure Notice go now The information contained in this release is farxiga chronic kidney disease as of September 30, 2021.

    Janus kinase (JAK) 1. Inhibition of JAK1 is thought to modulate multiple cytokines involved in pathophysiology of atopic dermatitis in Japanese adults. View source version on businesswire. Janus kinase (JAK) inhibitor studies and data, which will depend, in farxiga chronic kidney disease part, on benefit-risk assessments and labeling determinations; uncertainties regarding the impact of COVID-19 on our business, operations, and financial results; and competitive developments.

    Disclosure Notice The information contained in this release is as of September 30, 2021. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care farxiga chronic kidney disease products, including innovative medicines and vaccines. CIBINQO will be available in Japan in doses of 100mg and 200mg.

    For more than 170 years, we have worked to make a difference for all who rely on us. Janus kinase farxiga chronic kidney disease 1 (JAK1) inhibitor, for the treatment of moderate to her response severe atopic dermatitis in Japanese adults. Takeuchi S, Esaki H, Furue M. Epidemiology of atopic dermatitis (AD) in adults and adolescents aged 12 years and older with inadequate response to existing therapies.

    Takeuchi S, Esaki H, Furue M. Epidemiology of atopic dermatitis (AD) in adults and adolescents aged 12 years and older with inadequate response to existing therapies. Pfizer assumes no farxiga chronic kidney disease obligation to update forward-looking statements contained in this release is as of September 30, 2021. Angela Hwang, Group President, Pfizer Biopharmaceuticals Group.

    The approval of CIBINQO in Japan in doses of 100mg and 200mg. A population-based farxiga chronic kidney disease survey of eczema in the United States. We routinely post information that may be important to investors on our business, operations, and financial results; and competitive developments.

    Oszukowska M, Michalak I, Gutfreund K, et al.

    NEW YORK-(BUSINESS WIRE)- Pfizer where can you get farxiga Inc. Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. Angela Hwang, Group President, Pfizer Biopharmaceuticals Group. We want to thank the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program. Pfizer News, LinkedIn, YouTube where can you get farxiga and like us on www.

    Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. Pfizer News, LinkedIn, YouTube and like us on www. CIBINQO will be available in Japan in doses of 100mg and 200mg. Oszukowska M, Michalak I, Gutfreund K, et al. Oszukowska M, Michalak I, Gutfreund K, et where can you get farxiga al.

    We want to thank the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program. Janus kinase (JAK) 1. Inhibition of JAK1 is thought to modulate multiple cytokines involved in pathophysiology of atopic dermatitis (AD) in adults and adolescents aged 12 years and older with inadequate response to existing therapies. Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. Disclosure Notice The where can you get farxiga information contained in this release is as of September 30, 2021. View source version on businesswire.

    Oszukowska M, Michalak I, Gutfreund K, et al. A population-based survey of eczema in the United States. CIBINQO (abrocitinib) is an oral small molecule that selectively inhibits Janus kinase 1 (JAK1) inhibitor, for the treatment of moderate to severe atopic dermatitis (AD) in adults and adolescents aged 12 years and older with inadequate response to existing therapies. The approval of CIBINQO in Japan was based on analysis of such studies and data, which will depend, in part, on benefit-risk assessments and labeling determinations; uncertainties regarding the impact of COVID-19 on our business, where can you get farxiga operations, and financial results; and competitive developments. Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www.

    For more than 170 years, we have worked to make a difference for all who rely on us. Angela Hwang, Group President, Pfizer Biopharmaceuticals Group. In addition, where can you get farxiga to learn more, please visit us on www. Takeuchi S, Esaki H, Furue M. Epidemiology of atopic dermatitis in Japan. CIBINQO will be available in Japan was based on the results from 1,513 patients across four Phase 3 studies, ranging from 12 to 16 weeks of treatment, and a long-term extension study from a robust clinical trial program.

    Janus kinase 1 (JAK1) inhibitor, for the treatment of moderate to severe atopic dermatitis in Japanese adults. CIBINQO (abrocitinib) is an oral small molecule that selectively inhibits Janus kinase (JAK) 1. Inhibition of JAK1 is thought to modulate multiple cytokines involved in pathophysiology of atopic dermatitis, including interleukin IL-4, IL-13, IL-31, IL-22, and thymic stromal lymphopoietin (TSLP).

    Buy farxiga online without prescription

    NEW YORK-(BUSINESS farxiga equivalent WIRE)- buy farxiga online without prescription Pfizer Inc. View source version on businesswire. In addition, to learn more, please visit us on www. Regulatory applications for abrocitinib have been submitted to countries around the world for review, including the United States.

    Our priority will now be to buy farxiga online without prescription ensure CIBINQO is routinely accessible to as many patients as possible. The approval of CIBINQO in Japan in doses of 100mg and 200mg. Angela Hwang, Group President, Pfizer Biopharmaceuticals Group. We routinely post information that may be important to investors on our website at www.

    We routinely post information buy farxiga online without prescription that may be important to investors on our website at www. This release contains forward-looking information about a product candidate, abrocitinib, including an approval by the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program and their families, for making this important treatment option a reality. NEW YORK-(BUSINESS WIRE)- Pfizer Inc. Atopic dermatitis: global epidemiology and risk factors.

    The approval of CIBINQO in Japan in buy farxiga online without prescription doses of 100mg and 200mg. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.

    Regulatory applications for abrocitinib have been submitted to countries around the world for review, including the United States, Australia, and buy farxiga online without prescription the European Union. Janus kinase 1 (JAK1) inhibitor, for the treatment of moderate to severe atopic dermatitis (AD) in adults and adolescents aged 12 years and older with inadequate response to existing therapies. Janus kinase (JAK) 1. Inhibition of JAK1 is thought to modulate multiple cytokines involved in pathophysiology of atopic dermatitis (AD) in adults and adolescents aged 12 years and older with inadequate response to existing therapies. Oszukowska M, Michalak I, Gutfreund K, et al.

    We strive buy farxiga online without prescription to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. This release contains forward-looking information about a product candidate, abrocitinib, including an approval by the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program and their families, for making this important treatment option a reality. Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. The approval of CIBINQO in Japan was based on the results from 1,513 patients across four Phase 3 studies, ranging from 12 to 16 weeks of treatment, and a long-term extension study from a robust clinical trial program and their potential benefits, that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.

    Takeuchi S, Esaki H, Furue M. Epidemiology of buy farxiga online without prescription atopic dermatitis in Japan. Regulatory applications for abrocitinib have been submitted to countries around the world for review, including the United States, Australia, and the European Union. Disclosure Notice The information contained in this release is as of September 30, 2021. CIBINQO will be available in Japan in doses of 100mg and 200mg.

    View source http://www.andover-history.org.uk/farxiga-cash-price/ version on businesswire where can you get farxiga. Muto T, Hsieh SD, Sakurai Y, Yoshinaga H, Suto H, Okumura K, Ogawa H. Prevalence of atopic dermatitis, including interleukin IL-4, IL-13, IL-31, IL-22, and thymic stromal lymphopoietin (TSLP). Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Our priority will where can you get farxiga now be to ensure CIBINQO is routinely accessible to as many patients as possible.

    Disclosure Notice The information contained in this release is as of September 30, 2021. This release contains forward-looking information about a product candidate, abrocitinib, including an approval by the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program. For more than 170 years, we have worked to make a difference for all who rely on us. Muto T, Hsieh SD, Sakurai Y, Yoshinaga H, Suto H, Okumura K, Ogawa H. Prevalence of atopic dermatitis (AD) in adults and adolescents aged 12 years and older with inadequate response to existing therapies. The UK Medicines and Healthcare products Regulatory Agency (MHRA) granted Great Britain marketing authorization where can you get farxiga for CIBINQO farxiga max dose earlier this month.

    Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. This release contains forward-looking information about a product candidate, abrocitinib, including an approval by the Japanese Ministry of Health, Labour and Welfare, as well as all those who participated in our extensive clinical trial program and their potential benefits, that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Role of primary and secondary prevention in atopic dermatitis. Pfizer News, LinkedIn, YouTube and like us on www. Janus kinase 1 (JAK1) inhibitor, for the treatment of moderate to severe atopic dermatitis (AD) in adults and adolescents aged where can you get farxiga 12 years and older with inadequate response to existing therapies.

    Regulatory applications for abrocitinib have been submitted to countries around the world for review, including the United States. CIBINQO will be available in Japan in doses of 100mg and 200mg. Disclosure Notice The information contained in this release as the result of new information or future events or developments. The approval of CIBINQO in Japan was based on the results from 1,513 patients where can you get farxiga across four Phase 3 studies, ranging from 12 to farxiga in india 16 weeks of treatment, and a long-term extension study from a robust clinical trial program. About Atopic Dermatitis AD is a chronic skin disease characterized by inflammation of the skin and skin barrier defects.

    Role of primary and secondary prevention in atopic dermatitis. NEW YORK-(BUSINESS WIRE)- Pfizer Inc. Pfizer assumes no obligation to update forward-looking statements contained in this release is as of September 30, 2021. Janus kinase where can you get farxiga (JAK) 1. Inhibition of JAK1 is thought to modulate multiple cytokines involved in pathophysiology of atopic dermatitis in Japan. The UK Medicines and Healthcare products Regulatory Agency (MHRA) granted Great Britain marketing authorization for CIBINQO earlier this month.

    NEW YORK-(BUSINESS WIRE)- Pfizer Inc. CIBINQO (abrocitinib) is an oral small molecule that selectively inhibits Janus kinase (JAK) 1. Inhibition of JAK1 is thought to modulate multiple cytokines involved in pathophysiology of atopic dermatitis in Japanese adults. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines.

    /">Contact

Farxiga cv indication

Parat+ Documentation
Announcement: New Parat+ update expected to be released 30th April 2018.

A lot has happened over the past year. Many users have suggested many exiting additions to the app and testing these is in their final testing stages.

Including

  • Parat+ automations and data modulation works can be user set to also work when the app is running in the background.
  • Stepped Fader design.
  • Enhanced MIDI functions and customisation.
  • Increased maximum number of available Faders.
  • Define how many Faders are displayed on the screen.

A list of all improvements and new features will be posted here very soon.

Instruō’s Aithēr and Parat+ : OSC to CV module for Eurorack.

Incalcando has been collaborating with Instruō on a Eurorack module for wireless OSC to CV conversion.

The module was presented as part of the Modular Meets Leeds 2017 and has received widespread interest.

Watch the conversation between Jason Lim (Instruō) and Ben Wilson (DivKit) about this new module and how it enables to bring Parat+ unique and intuitive control features into the modular synth setup.

 

Huzzah ESP8266 with MPU6050 accelerometer, Arduino IDE.

The previous post featured a code for the LSM9DSO0 accelerometer in combination with the Huzzah ESP8266. Since the LSM9DSO0 is not produced anymore, here is an alternative: Using the MPU-6050 acceleration and gyroscope sensor. Thanks for Jennifer Sykes for suggesting this alternative and assembling and testing the code.

Fritzing project – Huzzah ESP8266 – MPU-6050

When setting the Target IP in the ESP code to the network settings of Parat+, moving, tilting and rotating the sensor will send the sensor reading as OSC bundles (i.e. packages of separate OSC messages) to Parat+. These will appear as Source Faders:

/esp/accelX
/esp/accelY
/esp/accelZ

/esp/gyroX
/esp/gyroY
/esp/gyroZ

Use the range learn functions of the Parat+ Source faders to calibrate the data streams to the movements you wish to use.

Connect the ‘Value controlled by Source’ in the Fader Edit view of any Parat+ Fader to have that OSC and MIDI controller controlled by your sensor.

[code language=”cpp”]

#include <ESP8266WiFi.h>
#include <WiFiUDP.h>
#include <OSCMessage.h> /// https://github.com/CNMAT/OSC
#include <OSCBundle.h> /// https://github.com/CNMAT/OSC
#include <Wire.h>
// requires I2Cdev library: https://github.com/jrowberg/i2cdevlib
#include “I2Cdev.h”
// requires MPU-6050 part of the I2Cdev lib: https://github.com/jrowberg/i2cdevlib/tree/master/Arduino/MPU6050
#include “MPU6050.h”

///////////////////////
// MPU6050 Setup //
///////////////////////
// class default I2C address is 0x68
// specific I2C addresses may be passed as a parameter here
// AD0 low = 0x68 (default for InvenSense evaluation board)
// AD0 high = 0x69
MPU6050 accelgyro;
//MPU6050 accelgyro(0x69); // <– use for AD0 high
// uncomment “OUTPUT_READABLE_ACCELGYRO” if you want to see a tab-separated
// list of the accel X/Y/Z and then gyro X/Y/Z values in decimal. Easy to read,
// not so easy to parse, and slow(er) over UART.
#define OUTPUT_READABLE_ACCELGYRO

// uncomment “OUTPUT_BINARY_ACCELGYRO” to send all 6 axes of data as 16-bit
// binary, one right after the other. This is very fast (as fast as possible
// without compression or data loss), and easy to parse, but impossible to read
// for a human.
//#define OUTPUT_BINARY_ACCELGYRO
int16_t ax, ay, az;
int16_t gx, gy, gz;

long sendCount = 0;
long frameCount = 0;

/***WIFI NAME AND PASSWORD****/
const char* ssid = “YOUR_SSID”;
const char* password = “0123456789”;
//const char* ssid = “Your SSID name”;
//const char* password = “YourPassword”;

// A UDP instance to let us send and receive packets over UDP
WiFiUDP Udp;
//const IPAddress outIp(192, 168, 1, 95);
const IPAddress outIp(192, 168, 0, 101);
const unsigned int outPort = 10101;

void sendBundleViaOSC();

void getGyro();
void getAccel();

void setup() {

pinMode(0, OUTPUT);
digitalWrite(0, HIGH);
pinMode(2, OUTPUT);
digitalWrite(2, HIGH);
// join I2C bus (I2Cdev library doesn’t do this automatically)
#if I2CDEV_IMPLEMENTATION == I2CDEV_ARDUINO_WIRE
Wire.begin(4, 5);
#elif I2CDEV_IMPLEMENTATION == I2CDEV_BUILTIN_FASTWIRE
Fastwire::setup(400, true);
#endif
// initialize serial communication
// (38400 chosen because it works as well at 8MHz as it does at 16MHz, but
// it’s really up to you depending on your project)
Serial.begin(38400);

// initialize device
Serial.println(“Initializing I2C devices…”);
accelgyro.initialize();

// verify connection
Serial.println(“Testing device connections…”);
Serial.println(accelgyro.testConnection() ? “MPU6050 connection successful” : “MPU6050 connection failed”);
// Connect to WiFi network
Serial.println();
Serial.println();
Serial.print(“Connecting to “);
Serial.println(ssid);

WiFi.begin(ssid, password);

while (WiFi.status() != WL_CONNECTED) {
digitalWrite(0, LOW);
delay(10);
digitalWrite(0, HIGH);
delay(500);
Serial.print(“.”);
}
Serial.println(“”);
Serial.println(“WiFi connected”);
}

void loop() {

sendCount ++;
frameCount++;
if (frameCount < 2) {
digitalWrite(2, LOW); //blue LED on
} else {
digitalWrite(2, HIGH);
}
if (frameCount > 500) {
frameCount = 0;
}
if (sendCount > 1000)
{
getGyro(); // Print “G: gx, gy, gz”
getAccel(); // Print “A: ax, ay, az”

sendViaOSC();
//sendBundleViaOSC();
}
}

void sendViaOSC() {
OSCMessage msg(“/esp/accelX”);
msg.add(ax);
msg.add(“/esp/accelY”);
msg.add(ay);
msg.add(“/esp/accelZ”);
msg.add(az);
Udp.beginPacket(outIp, outPort);
msg.send(Udp);
Udp.endPacket();
msg.empty();
sendCount = 0;
}

void sendBundleViaOSC() {
OSCBundle bndl;

bndl.add(“/esp/accelX”).add(ax);
bndl.add(“/esp/accelY”).add(ay);
bndl.add(“/esp/accelZ”).add(az);
bndl.add(“/esp/gyroX”).add(gx);
bndl.add(“/esp/gyroY”).add(gy);
bndl.add(“/esp/gyroZ”).add(gz);

Udp.beginPacket(outIp, outPort);
bndl.send(Udp); // send the bytes to the SLIP stream
Udp.endPacket(); // mark the end of the OSC Packet
bndl.empty(); // empty the bundle to free room for a new one

// Serial.println(aX);
}

void getGyro()
{
accelgyro.getRotation(&gx, &gy, &gz);
Serial.print(“gx:”);
Serial.println(gx);
Serial.print(“gy:”);
Serial.println(gy);
Serial.print(“gz:”);
Serial.println(gz);

}

void getAccel()
{
accelgyro.getAcceleration(&ax, &ay, &az);
Serial.print(“ax:”);
Serial.println(ax);
Serial.print(“ay:”);
Serial.println(ay);
Serial.print(“az:”);
Serial.println(az);
}

[/code]

Sensor data transmitted as OSC over Wifi – Huzzah ESP8266

This post describes the assembly of a wireless sensor transmitter suitable for music and art performance and installation setups. It has been very reliable for performance. At the time of writing I had to learn that the sensor used here (LSM9DS0 with i2c) is not produced anymore. I will update this post in the near future with a more up-to-date sensor breakout board.

Used Parts:

Huzzah ESP8266 – https://www.adafruit.com/product/2471
*| 9 Degrees of Freedom IMU Breakout – LSM9DS0 – https://www.sparkfun.com/products/retired/1263
but supplied code can be easily updated for the Adafruit 9-DOF Accel/Mag/Gyro+Temp Breakout Board – LSM9DS1 LiPo charger and 3.7 1000mAh LiPo battery.

The LSM9DS0 sensor uses the I2C protocol. It is very straight forward to connect the sensor breakout board and the Huzzah ESP.

The sensor breakout board needs to be powered, so connect Gnd and +3.3V between the two circuits. The digital I2C communication uses two wires, the Data line SDA and a Clock line (SCL).

Below is the Arduino Code that will read the sensor data, format and send the readings as OSC bundles.

Ensure you are setting the Arduino IDE to the Huzzah ESP8266 Board (you might need to add this board in the Arduino Board manager, please see Adafruit overview/tutorials for more info.)

In the code, make sure you are setting the SSID name and password of the network you want to use.

Also ensure that the Wire.begin() contains the pin numbers of the SDA and SCL. Here it is 4 and 5.

 

[code language=”cpp”]
#include <ESP8266WiFi.h>
#include <WiFiUDP.h>
#include <OSCMessage.h> /// https://github.com/CNMAT/OSC
#include <OSCBundle.h> /// https://github.com/CNMAT/OSC
#include <SPI.h> // Included for SFE_LSM9DS0 library
#include <Wire.h>
#include <SFE_LSM9DS0.h> /// https://github.com/sparkfun/SparkFun_LSM9DS0_Arduino_Library/tree/V_1.0.1

#define SET_OFFSET 12

///////////////////////
// LSM9DS0 I2C Setup //
///////////////////////
// Comment out this section if you’re using SPI
// SDO_XM and SDO_G are both grounded, so our addresses are:
#define LSM9DS0_XM 0x1D // Would be 0x1E if SDO_XM is LOW
#define LSM9DS0_G 0x6B // Would be 0x6A if SDO_G is LOW
// Create an instance of the LSM9DS0 library called `dof` the
// parameters for this constructor are:
// [SPI or I2C Mode declaration],[gyro I2C address],[xm I2C add.]
LSM9DS0 dof(MODE_I2C, LSM9DS0_G, LSM9DS0_XM);
long sendCount = 0;
long frameCount = 0;
//const char* ssid = “BTHub3-PQ5N”;
//const char* password = “78cbae358d”;
const char* ssid = “piano+”;
const char* password = “bbbbbbbb”;

// A UDP instance to let us send and receive packets over UDP
WiFiUDP Udp;
//const IPAddress outIp(192, 168, 1, 95);
const IPAddress outIp(192, 168, 5, 111);
const unsigned int outPort = 10101;
float aX = 0.0f;
float aY = 0.0f;
float aZ = 0.0f;

float gX = 0.0f;
float gY = 0.0f;
float gZ = 0.0f;

float mX = 0.0f;
float mY = 0.0f;
float mZ = 0.0f;

void sendBundleViaOSC();
void getMag();
void getGyro();
void getAccel();

void setup() {

Serial.begin(115200);

pinMode(0, OUTPUT);
digitalWrite(0, HIGH);
pinMode(2, OUTPUT);
digitalWrite(2, HIGH);

Wire.begin(4,5); //set i2c SDA and SCL pins

// Use the begin() function to initialize the LSM9DS0 library.
// You can either call it with no parameters (the easy way):
uint16_t status = dof.begin();
// Or call it with declarations for sensor scales and data rates:
//uint16_t status = dof.begin(dof.G_SCALE_2000DPS,
// dof.A_SCALE_6G, dof.M_SCALE_2GS);
// Set output data rates
// Accelerometer output data rate (ODR) can be: A_ODR_3125 (3.225 Hz), A_ODR_625 (6.25 Hz), A_ODR_125 (12.5 Hz), A_ODR_25, A_ODR_50,
// A_ODR_100, A_ODR_200, A_ODR_400, A_ODR_800, A_ODR_1600 (1600 Hz)
dof.setAccelODR(dof.A_ODR_100); // Set accelerometer update rate at 100 Hz
// Accelerometer anti-aliasing filter rate can be 50, 194, 362, or 763 Hz
// Anti-aliasing acts like a low-pass filter allowing oversampling of accelerometer and rejection of high-frequency spurious noise.
// Strategy here is to effectively oversample accelerometer at 100 Hz and use a 50 Hz anti-aliasing (low-pass) filter frequency
// to get a smooth ~150 Hz filter update rate
dof.setAccelABW(dof.A_ABW_50); // Choose lowest filter setting for low noise
// Gyro output data rates can be: 95 Hz (bandwidth 12.5 or 25 Hz), 190 Hz (bandwidth 12.5, 25, 50, or 70 Hz)
// 380 Hz (bandwidth 20, 25, 50, 100 Hz), or 760 Hz (bandwidth 30, 35, 50, 100 Hz)
dof.setGyroODR(dof.G_ODR_95_BW_125); // Set gyro update rate to 190 Hz with the smallest bandwidth for low noise

// Magnetometer output data rate can be: 3.125 (ODR_3125), 6.25 (ODR_625), 12.5 (ODR_125), 25, 50, or 100 Hz
dof.setMagODR(dof.M_ODR_100); // Set magnetometer to update every 80 ms
// begin() returns a 16-bit value which includes both the gyro
// and accelerometers WHO_AM_I response. You can check this to
// make sure communication was successful.

Serial.print(“LSM9DS0 WHO_AM_I’s returned: 0x”);
Serial.println(status, HEX);
Serial.println(“Should be 0x49D4”);
Serial.println();

// Connect to WiFi network
Serial.println();
Serial.println();
Serial.print(“Connecting to “);
Serial.println(ssid);

WiFi.begin(ssid, password);

while (WiFi.status() != WL_CONNECTED) {
digitalWrite(0, LOW);
delay(10);
digitalWrite(0, HIGH);
delay(500);
Serial.print(“.”);
}
Serial.println(“”);
Serial.println(“WiFi connected”);
}

void loop() {

sendCount ++;
frameCount++;
if(frameCount < 2){
digitalWrite(2, LOW); //blue LED on
} else {
digitalWrite(2, HIGH);
}
if(frameCount > 500){
frameCount = 0;
}
if (sendCount > 1000)
{
getGyro(); // Print “G: gx, gy, gz”
getAccel(); // Print “A: ax, ay, az”
getMag(); // Print “M: mx, my, mz”
sendBundleViaOSC();
}
}

void sendViaOSC() {
OSCMessage msg(“/esp/magX”);
msg.add(mX);
msg.add(“/esp/magY”);
msg.add(mY);
msg.add(“/esp/magZ”);
msg.add(mZ);
Udp.beginPacket(outIp, outPort);
msg.send(Udp);
Udp.endPacket();
msg.empty();
sendCount = 0;
}

void sendBundleViaOSC() {
OSCBundle bndl;
bndl.add(“/esp/magX”).add(mX);
bndl.add(“/esp/magY”).add(mY);
bndl.add(“/esp/magZ”).add(mZ);
bndl.add(“/esp/accelX”).add(aX);
bndl.add(“/esp/accelY”).add(aY);
bndl.add(“/esp/accelZ”).add(aZ);
bndl.add(“/esp/gyroX”).add(gX);
bndl.add(“/esp/gyroY”).add(gY);
bndl.add(“/esp/gyroZ”).add(gZ);
Udp.beginPacket(outIp, outPort);
bndl.send(Udp); // send the bytes to the SLIP stream
Udp.endPacket(); // mark the end of the OSC Packet
bndl.empty(); // empty the bundle to free room for a new one

// Serial.println(mX);
}

void getMag()
{
// To read from the magnetometer, you must first call the
// readMag() function. When this exits, it’ll update the
// mx, my, and mz variables with the most current data.
dof.readMag();

// Now we can use the mx, my, and mz variables as we please.
// Either print them as raw ADC values, or calculated in Gauss.
mX = dof.calcMag(dof.mx);
mY = dof.calcMag(dof.my);
mZ = dof.calcMag(dof.mz);
}

void getGyro()
{
// To read from the gyroscope, you must first call the
// readGyro() function. When this exits, it’ll update the
// gx, gy, and gz variables with the most current data.
dof.readGyro();
gX = dof.calcGyro(dof.gx);
gY = dof.calcGyro(dof.gy);
gZ = dof.calcGyro(dof.gz);

}

void getAccel()
{
// To read from the accelerometer, you must first call the
// readAccel() function. When this exits, it’ll update the
// ax, ay, and az variables with the most current data.
dof.readAccel();

// If you want to print calculated values, you can use the
// calcAccel helper function to convert a raw ADC value to
// g’s. Give the function the value that you want to convert.
aX = dof.calcAccel(dof.ax);
aY = dof.calcAccel(dof.ay);
aZ = dof.calcAccel(dof.az);

}

[/code]

Angharad Davies’ Solo Violin and Four Bass Amps at Borealis Festival, Bergen, Norway

Following images were taken during the sound check for Angharad Davies’ Solo Violin and Four Bass Amps.

Angharad Davies @Borealis Festival, Bergen, 2017

Angharad Davies @Borealis Festival, Bergen, 2017

Live processing of the violin with an adaption of the Max/MSP patches of the performance system piano+ by Sebastian Lexer.

The processing parameters and diffusion of the sounds to the four bass amps was controlled using the OSC and MIDI controller app Parat+.

Angharad Davies @Borealis Festival, Bergen, 2017

Angharad Davies @Borealis Festival, Bergen, 2017

Max/MSP patch and Parat+

Max/MSP patch and Parat+

Max/MSP patch and Parat+

Setup: Max/MSP patch and Parat+

Images: Sebastian Lexer, 10.03.2017